Regueiro Ander, Bosch Julia, Martín-Yuste Victoria, Rosas Alba, Faixedas Maria Teresa, Gómez-Hospital Joan Antoni, Figueras Jaume, Curós Antoni, Cequier Angel, Goicolea Javier, Fernández-Ortiz Antonio, Macaya Carlos, Tresserras Ricard, Pellisé Laura, Sabaté Manel
Servicio de Cardiología, Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Universitat de Barcelona, Barcelona, Spain Iniciativa Stent for Life, Spain.
Centro de Investigación en Economía y Salud, Universidad Pompeu Fabra, Barcelona, Spain.
BMJ Open. 2015 Dec 9;5(12):e009148. doi: 10.1136/bmjopen-2015-009148.
To evaluate the cost-effectiveness of the ST-segment elevation myocardial infarction (STEMI) network of Catalonia (Codi Infart).
Cost-utility analysis.
The analysis was from the Catalonian Autonomous Community in Spain, with a population of about 7.5 million people.
Patients with STEMI treated within the autonomous community of Catalonia (Spain) included in the IAM CAT II-IV and Codi Infart registries.
Costs included hospitalisation, procedures and additional personnel and were obtained according to the reperfusion strategy. Clinical outcomes were defined as 30-day avoided mortality and quality-adjusted life-years (QALYs), before (N=356) and after network implementation (N=2140).
A substitution effect and a technology effect were observed; aggregate costs increased by 2.6%. The substitution effect resulted from increased use of primary coronary angioplasty, a relatively expensive procedure and a decrease in fibrinolysis. Primary coronary angioplasty increased from 31% to 89% with the network, and fibrinolysis decreased from 37% to 3%. Rescue coronary angioplasty declined from 11% to 4%, and no reperfusion from 21% to 4%. The technological effect was related to improvements in the percutaneous coronary intervention procedure that increased efficiency, reducing the average length of the hospital stay. Mean costs per patient decreased from €8306 to €7874 for patients with primary coronary angioplasty. Clinical outcomes in patients treated with primary coronary angioplasty did not change significantly, although 30-day mortality decreased from 7.5% to 5.6%. The incremental cost-effectiveness ratio resulted in an extra cost of €4355 per life saved (30-day mortality) and €495 per QALY. Below a cost threshold of €30,000, results were sensitive to variations in costs and outcomes.
The Catalan STEMI network (Codi Infart) is cost-efficient. Further studies are needed in geopolitical different scenarios.
评估加泰罗尼亚ST段抬高型心肌梗死(STEMI)网络(Codi Infart)的成本效益。
成本效用分析。
分析来自西班牙加泰罗尼亚自治区,人口约750万。
纳入IAM CAT II-IV和Codi Infart登记处的西班牙加泰罗尼亚自治区内接受治疗的STEMI患者。
成本包括住院、手术及额外人员费用,并根据再灌注策略获取。临床结局定义为网络实施前(n = 356)和实施后(n = 2140)30天避免的死亡率和质量调整生命年(QALY)。
观察到替代效应和技术效应;总成本增加了2.6%。替代效应源于相对昂贵的主要冠状动脉血管成形术使用增加以及纤维蛋白溶解减少。随着该网络的建立,主要冠状动脉血管成形术的使用率从31%增至89%,纤维蛋白溶解从37%降至3%。补救性冠状动脉血管成形术从11%降至4%,未进行再灌注治疗从21%降至4%。技术效应与经皮冠状动脉介入手术效率提高有关,这缩短了平均住院时间。接受主要冠状动脉血管成形术的患者人均成本从8306欧元降至7874欧元。接受主要冠状动脉血管成形术治疗的患者临床结局无显著变化,尽管30天死亡率从7.5%降至5.6%。增量成本效益比为每挽救一条生命(30天死亡率)额外花费4355欧元,每QALY花费495欧元。低于30000欧元的成本阈值时,结果对成本和结局的变化敏感。
加泰罗尼亚STEMI网络(Codi Infart)具有成本效益。需要在地缘政治不同的情况下进行进一步研究。